The objective of this study is to evaluate the safety and efficacy of ADHEXIL™ in preventing and/or reducing post-operative adhesions in patients undergoing surgery involving the ovaries.
Patients will be divided into two arms: 1) patients who will be treated in accordance with standard of care; 2) patients for which ADHEXIL™ will be applied on one ovary and fallopian tube.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
80
Adhesions prevention
Unnamed facility
Richmond, Virginia, United States
Unnamed facility
Duisburg, Germany
Unnamed facility
Mexico City, Mexico
Unnamed facility
Moscow, Russia
Unnamed facility
Valencia, Spain
Adhesions will be assessed according to incidence, extent and severity.
Time frame: 8 weeks post surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.